You are here
ONECYTE BIOTECHNOLOGIES INC
UEI: ERE5JFD78JB9
# of Employees: 2
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
A proprietary single-cell analytics platform for accelerating biologics manufacturing
Amount: $1,710,528.00Project Summary:OneCyte Biotechnologies, Inc. is a spin-out from the Massachusetts Institute of Technology (MIT) advancing next-generation single-cell technologies to impact drug development and bio-m ...
SBIRPhase II2021Department of Health and Human Services National Institutes of Health -
SBIR Phase I: A high throughput microfluidic platform to accelerate biomanufacturing transitions in the COVID-19 response
Amount: $256,000.00The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project aims to address a key challenge in the response to COVID-19, namely manufacturing sufficient q ...
SBIRPhase I2020National Science Foundation -
SBIR Phase I: A High Throughput Microfluidics Platform to Measure Secretion from Single Cells
Amount: $225,000.00The broader impact/commercial potential of this Small Business Innovation Research (SBIR) project is to develop single cell analysis technology to provide insight into cellular mechanisms, which has t ...
SBIRPhase I2018National Science Foundation